Literature DB >> 26227857

Fluorescence assay of the interaction between hemoglobin and the cytoplasmic domain of erythrocyte membrane band 3.

Martiana F Sega1, Haiyan Chu2, John A Christian3, Philip S Low4.   

Abstract

Oxygen tension has emerged as a potent regulator of multiple erythrocyte properties, including glucose metabolism, cell volume, ATP release, and cytoskeletal organization. Because hemoglobin (Hb)(1) binds to the cytoplasmic domain of band 3 (cdb3) in an oxygen dependent manner, with deoxyHb exhibiting significantly greater affinity for cdb3 than oxyHb, the deoxyHb-cdb3 interaction has been hypothesized to constitute the molecular switch for all O2-controlled erythrocyte processes. In this study, we describe a rapid and accurate method for quantitating the interaction of deoxyHb binding to cdb3. For this purpose, enhanced green fluorescent protein (eGFP) is fused to the COOH-terminus of cdb3, and the binding of Hb to the NH2-terminus of cdb3-eGFP is quantitated by Hb-mediated quenching of cdb3-eGFP fluorescence. As expected, the intensity of cdb3-eGFP fluorescence decreases only slightly following addition of oxyHb. However, upon deoxygenation of the same Hb-cdb3 solution, the fluorescence decreases dramatically (i.e. confirming that deoxyHb exhibits much greater affinity for cdb3 than oxyHb). Using this fluorescence quenching method, we not only confirm previously established characteristics of the Hb-cdb3 interaction, but also establish an assay that can be exploited to screen for inhibitors of the sickle Hb-cdb3 interaction that accelerates sickle Hb polymerization.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FRET analysis; Hemoglobin; Protein structure; Red blood cells; anion exchanger 1

Mesh:

Substances:

Year:  2015        PMID: 26227857      PMCID: PMC5013544          DOI: 10.1016/j.bcmd.2015.07.004

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  50 in total

1.  Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3.

Authors:  D Zhang; A Kiyatkin; J T Bolin; P S Low
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

2.  Mild spherocytosis and altered red cell ion transport in protein 4. 2-null mice.

Authors:  L L Peters; H K Jindel; B Gwynn; C Korsgren; K M John; S E Lux; N Mohandas; C M Cohen; M R Cho; D E Golan; C Brugnara
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

3.  Identification of a critical ankyrin-binding loop on the cytoplasmic domain of erythrocyte membrane band 3 by crystal structure analysis and site-directed mutagenesis.

Authors:  Seon Hee Chang; Philip S Low
Journal:  J Biol Chem       Date:  2002-12-12       Impact factor: 5.157

4.  Identification of the major casein kinase I phosphorylation sites on erythrocyte band 3.

Authors:  C C Wang; M Tao; T Wei; P S Low
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

Review 5.  Erythrocyte signal transduction pathways, their oxygenation dependence and functional significance.

Authors:  Nadezhda N Barvitenko; Norma C Adragna; Roy E Weber
Journal:  Cell Physiol Biochem       Date:  2005

6.  A band 3-based macrocomplex of integral and peripheral proteins in the RBC membrane.

Authors:  Lesley J Bruce; Roland Beckmann; M Leticia Ribeiro; Luanne L Peters; Joel A Chasis; Jean Delaunay; Narla Mohandas; David J Anstee; Michael J A Tanner
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

7.  Characterization of glycolytic enzyme interactions with murine erythrocyte membranes in wild-type and membrane protein knockout mice.

Authors:  M Estela Campanella; Haiyan Chu; Nancy J Wandersee; Luanne L Peters; Narla Mohandas; Diana M Gilligan; Philip S Low
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

8.  Increased rotational mobility and extractability of band 3 from protein 4.2-deficient erythrocyte membranes: evidence of a role for protein 4.2 in strengthening the band 3-cytoskeleton linkage.

Authors:  A C Rybicki; R S Schwartz; E J Hustedt; C E Cobb
Journal:  Blood       Date:  1996-10-01       Impact factor: 22.113

9.  Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia.

Authors:  G R Bergfeld; T Forrester
Journal:  Cardiovasc Res       Date:  1992-01       Impact factor: 10.787

10.  Influence of gemfibrozil on sulfate transport in human erythrocytes during the oxygenation-deoxygenation cycle.

Authors:  E Tellone; S Ficarra; R Scatena; B Giardina; A Kotyk; A Russo; D Colucci; E Bellocco; G Lagana'; A Galtieri
Journal:  Physiol Res       Date:  2007-07-26       Impact factor: 1.881

View more
  5 in total

1.  Myosin IIA interacts with the spectrin-actin membrane skeleton to control red blood cell membrane curvature and deformability.

Authors:  Alyson S Smith; Roberta B Nowak; Sitong Zhou; Michael Giannetto; David S Gokhin; Julien Papoin; Ionita C Ghiran; Lionel Blanc; Jiandi Wan; Velia M Fowler
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-02       Impact factor: 11.205

Review 2.  Effects of Hypoxia on Erythrocyte Membrane Properties-Implications for Intravascular Hemolysis and Purinergic Control of Blood Flow.

Authors:  Ryszard Grygorczyk; Sergei N Orlov
Journal:  Front Physiol       Date:  2017-12-22       Impact factor: 4.566

3.  Oxygen tension-mediated erythrocyte membrane interactions regulate cerebral capillary hyperemia.

Authors:  Sitong Zhou; Michael Giannetto; James DeCourcey; Hongyi Kang; Ning Kang; Yizeng Li; Suilan Zheng; Hetince Zhao; William R Simmons; Helen S Wei; David M Bodine; Philip S Low; Maiken Nedergaard; Jiandi Wan
Journal:  Sci Adv       Date:  2019-05-29       Impact factor: 14.136

Review 4.  Carbonyl Stress in Red Blood Cells and Hemoglobin.

Authors:  Olga V Kosmachevskaya; Natalia N Novikova; Alexey F Topunov
Journal:  Antioxidants (Basel)       Date:  2021-02-07

5.  Cation Homeostasis in Red Cells From Patients With Sickle Cell Disease Heterologous for HbS and HbC (HbSC Genotype).

Authors:  A Hannemann; D C Rees; S Tewari; J S Gibson
Journal:  EBioMedicine       Date:  2015-09-18       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.